Eli Lilly investors and analysts said they want to hear details from the company on how exactly it plans to grow U.S. sales ...

A local vascular surgeon has highlighted a simple injection that could alleviate leg pain for those experiencing heaviness or ...

The pop superstar, who scored six nominations this year and will be presenting, shut down the red carpet in a shocking outfit and some suggestive accessories Brittany Talarico is PEOPLE's Deputy ...

patients will have to source their own syringes for the injections. The move is an escalation of the battle between Lilly and Novo Nordisk in the fast-growing obesity drugs market, where Zepbound ...

The US Food and Drug Administration (FDA) has declared an end to the shortage of tirzepatide, the active ingredient in Eli Lilly’s popular weight loss medication Zepbound and diabetes drug Mounjaro.

A participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous Brenton Blanchet is a writer-reporter at PEOPLE. He has been working at PEOPLE ...

Roche Holding said the U.S. Food and Drug Administration approved a test to identify patients with a specific type of breast cancer. The Swiss pharmaceutical company said the FDA backed a label ...

These sweet and sticky chicken thighs are packed with flavour and simple to make. Best of all, this meal won’t leave you with stacks of washing up. To make the marinade, whisk together the honey ...

Fri, January 31, 2025 at 2:32 PM UTC ...

SAN DIEGO – In the wake of the U.S. Food and Drug Administration’s approval of Zepbound to treat moderate to severe obstructive sleep apnea, ResMed is ramping up its education to high-volume ...